Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-30
2008-03-18
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S541000
Reexamination Certificate
active
07345087
ABSTRACT:
Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.
REFERENCES:
patent: 2954380 (1960-09-01), Shapiro et al.
patent: 3218328 (1965-11-01), Shapiro et al.
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4179501 (1979-12-01), Szmuszkovicz
patent: 4598087 (1986-07-01), Horwell
patent: 4656182 (1987-04-01), Horwell
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4880800 (1989-11-01), Wallis et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5019588 (1991-05-01), Horwell et al.
patent: 5051428 (1991-09-01), Horwell et al.
patent: 5059620 (1991-10-01), Stout et al.
patent: 5492825 (1996-02-01), Jan et al.
patent: 5506257 (1996-04-01), MacLeod et al.
patent: 5597818 (1997-01-01), Sanguinetti et al.
patent: 5637583 (1997-06-01), MacLeod et al.
patent: 5670335 (1997-09-01), Jan et al.
patent: 5728535 (1998-03-01), Lester et al.
patent: 5734021 (1998-03-01), Lester et al.
patent: 5750537 (1998-05-01), Nomura et al.
patent: 5817698 (1998-10-01), Brown et al.
patent: 5885984 (1999-03-01), MacLeod et al.
patent: 6150357 (2000-11-01), Salata et al.
patent: 6174879 (2001-01-01), MacLeod et al.
patent: 6180632 (2001-01-01), Myers et al.
patent: 6210809 (2001-04-01), Okutomi et al.
patent: 6214810 (2001-04-01), Fermini et al.
patent: 6399618 (2002-06-01), Zolotoy et al.
patent: 6451819 (2002-09-01), Alanine et al.
patent: 6521619 (2003-02-01), Link et al.
patent: 6649603 (2003-11-01), Lum
patent: 6979685 (2005-12-01), Beatch et al.
patent: 7053087 (2006-05-01), Beatch et al.
patent: 7057053 (2006-06-01), Beatch et al.
patent: 7101877 (2006-09-01), Bain et al.
patent: 7259184 (2007-08-01), Beatch et al.
patent: 2005/0026993 (2005-02-01), Beatch et al.
patent: 2005/0038256 (2005-02-01), Barrett et al.
patent: 2005/0070552 (2005-03-01), Fedida et al.
patent: 2005/0119315 (2005-06-01), Fedida et al.
patent: 2005/0192208 (2005-09-01), Bain et al.
patent: 2005/0209307 (2005-09-01), Bain et al.
patent: 2006/0247300 (2006-11-01), Beatch et al.
patent: 2006/0252753 (2006-11-01), Beatch et al.
patent: 2007/0099983 (2007-05-01), Barrett et al.
patent: 2007/0197632 (2007-08-01), Beatch et al.
patent: 1234808 (1988-04-01), None
patent: 1235122 (1988-04-01), None
patent: 2004575 (1990-06-01), None
patent: 2058502 (1993-06-01), None
patent: 2172513 (1995-03-01), None
patent: 2244209 (1997-07-01), None
patent: 2240728 (1997-09-01), None
patent: 2008391 (1997-12-01), None
patent: 2289055 (1999-01-01), None
patent: 2268590 (2000-10-01), None
patent: 2132841 (2001-03-01), None
patent: 1303364 (2001-07-01), None
patent: 2 259 260 (1974-06-01), None
patent: 2 658 401 (1978-07-01), None
patent: 3 517 901 (1985-12-01), None
patent: 147085 (1985-07-01), None
patent: 222533 (1987-05-01), None
patent: 372466 (1990-06-01), None
patent: 380063 (1990-08-01), None
patent: 552386 (1993-07-01), None
patent: 720605 (2001-12-01), None
patent: 215963 (1995-02-01), None
patent: 02-270864 (1990-11-01), None
patent: WO 93/19056 (1993-09-01), None
patent: WO 94/07843 (1994-04-01), None
patent: WO 94/14435 (1994-07-01), None
patent: WO 95/08544 (1995-03-01), None
patent: WO 95/28155 (1995-10-01), None
patent: WO 96/18615 (1996-06-01), None
patent: WO 96/23894 (1996-08-01), None
patent: WO 97/32857 (1997-09-01), None
patent: WO 97/49680 (1997-12-01), None
patent: WO 99/02159 (1999-01-01), None
patent: WO 99/03468 (1999-01-01), None
patent: WO 99/11252 (1999-03-01), None
patent: WO 99/16431 (1999-04-01), None
patent: WO 99/50205 (1999-10-01), None
patent: WO 99/50225 (1999-10-01), None
patent: WO 00/47547 (2000-08-01), None
patent: WO 00/51981 (2000-09-01), None
patent: WO 01/96335 (2001-12-01), None
patent: WO 03/105756 (2003-12-01), None
patent: WO 2004/008103 (2004-01-01), None
patent: WO 2004/098525 (2004-11-01), None
patent: WO 2004/099137 (2004-11-01), None
Billman, “RSD-1235 Cardiome,” Current Opinion in Investigational Drugs, vol. 4, Issue 3, pp. 352-354 (2003).
Adcock, J.J. et al., (2003) “RSD931, a novel anti-tussive agent acting on airway sensory nerves” Br J Pharm, 138:407-416.
Allen I. Bain et al., “Ion Channel Modulating Compounds and Uses Thereof,” U.S. Appl. No. 09/283,873, filed Mar. 31, 1999, now abandoned.
Allen I. Bain et al., “Ion Channel Modulating Compounds and Uses Thereof,” U.S. Appl. No. 09/680,988, filed Oct. 6, 2000, now abandoned.
Altria, Kevin D. et al., (2001) “Capillary Electrophoresis as a Routine Analytical Tool in Pharmaceutical Analysis” LCGC 19(9): 972-985.
Amin et al., (1996) “RPR 101821, a New Potent Cholesterol-lowering Agent: Inhibition of Squalene Synthase and 7-Dehydrocholesterol Reductase”, Naunyn-Schmiedeberg's Arch Pharmacol 353:233-240.
Bain et al., (1997) “Better Antiarrhythmics?Development of Antiarrhythmic Drugs Selective for Ischaemia-Dependent Arrhythmias”, Drug Development Research 42:198-210.
Barret, T. D. et al., (1996) “Glibenclamide Possesses Transient, Ischaemia Selective Class III Antiarrhythmic Actions But does not Prevent Ischaemic Arrhythmias”BPS Proceedings 116P.
Barrett, T. D. et al., (1997) “A model of myocardial ischemia for the simultaneous assessment of electrophysiological changes and arrhythmias in intact rabbits” J Pharmacol Toxicol Methods, 37:27-36.
Barrett, T.D. (2000) “Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats” Eur J Pharm, 398:365-374.
Barrett, T.D. et al., (1996) “Atypical Dose Response curves for Antiarrhythmic Drugs” BPS Proceedings 115P.
Barrett, Terrance D. (1997) “Ischemia Selective Electrophysiological and antiarrhythmic actions of RSD1019 in ischemic cardiac tissue” J Mol Cell Cardiol, pp. 197.
Barrett, Terrance D. et al., (2000) “RSD 1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits” Br J Pharm, 131.405-414.
Beatch et al., (2002) “RSD1235 Selectively Prolongs Atrial Refractoriness and Terminates AF in Dogs with Electrically Remodelled Atria”, Pharmacologist, 44(2) (Supplement I), A15: XIVthWorld Congress of Pharmacology: Meeting Abstracts.
Beatch et al., (2002) “Selectively Prolongs Atrial Refractoriness and Terminates AF in Dogs with Electricially Remodeled Atria”, (NASPE) North Amer. Soc. of Pacing & Electrophysiol. 24:698 (Abstract 702).
Beatch, G. et al., “Effect of a Novel Anti-tussive Compound CPI Against Citric Acid Induced Cough in Guinea-Pigs”Proc West Pharmacol Soc, 2001.
Beatch, G. et al., “RSD1235 Rapidly and Effectively Terminates Atrial Fibrillation” Abstract submission ESC Congress Aug. 30-Sep. 3, 2003, in Vienna, Austria.
Beatch, G. N. et al., “RSD1235, A Novel Atrial-Selective Antiarrhythmic Drug, Shows Rapid and Extensive Oral Absorption in Man” 12thInternational Congress on Cardiovascular Pharmacotherapy, May 7-10, 2003, Barcelona, Spain.
Beatch, G. N. et al., (2002) “Ventricular Fibrillation, and Uncontrolled Arrhythmia Seeking New Targets” Drug Develop Res 55: 45-52.
Beatch, G.N. et al., (1996) “Antihistamine-induced Ventricular Arrhythmias” BPS Proceedings 120P.
Beatch, G.N. et al., (1997) “Characterization of a Non-Human Primate Model of Drug-Induced Torsades De Pointes” Proc. West. Pharmacol. Soc., 40: 13-16.
Bian et al., (1998) “Effects of K-opioid receptor stimulation in the heart and the involvement of protein kinase C” Brit. J. Pharmacol. 124:600-606.
Billman, (2003) “RSD-1235”, Current Opinion Investigational Drugs 4(3):352-354.
Boiadjiev et al., (1996) “pH-Sensitive Exciton Chirality Chromophore..Solvatochromic Effects on Circular Dichroism Spectra”, Tetrahedron: Asymmetry 7(10):2825-2832.
Bowen et al., (1992) ȁ
Beatch Gregory N.
Plouvier Bertrand M. C.
Sheng Tao
Walker Michael J. A.
Wall Richard A.
Cardiome Pharma Corp.
Saeed Kamal A.
Seed IP Law Group PLLC
LandOfFree
Aminocyclohexyl ether compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminocyclohexyl ether compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminocyclohexyl ether compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3970176